Literature DB >> 22869328

Immunotherapy: Harmonizing the immune response with a cancer vaccine.

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2012        PMID： 22869328     DOI： 10.1038/nrclinonc.2012.143

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.

Authors:  Steffen Walter; Toni Weinschenk; Arnulf Stenzl; Romuald Zdrojowy; Anna Pluzanska; Cezary Szczylik; Michael Staehler; Wolfram Brugger; Pierre-Yves Dietrich; Regina Mendrzyk; Norbert Hilf; Oliver Schoor; Jens Fritsche; Andrea Mahr; Dominik Maurer; Verona Vass; Claudia Trautwein; Peter Lewandrowski; Christian Flohr; Heike Pohla; Janusz J Stanczak; Vincenzo Bronte; Susanna Mandruzzato; Tilo Biedermann; Graham Pawelec; Evelyna Derhovanessian; Hisakazu Yamagishi; Tsuneharu Miki; Fumiya Hongo; Natsuki Takaha; Kosei Hirakawa; Hiroaki Tanaka; Stefan Stevanovic; Jürgen Frisch; Andrea Mayer-Mokler; Alexandra Kirner; Hans-Georg Rammensee; Carsten Reinhardt; Harpreet Singh-Jasuja
Journal:  Nat Med       Date:  2012-07-29       Impact factor: 53.440
  1 in total
  4 in total

1.  Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.

Authors:  Yuan Qi; Kailin Xing; Lanlin Zhang; Fangyu Zhao; Ming Yao; Aiqun Hu; Xianghua Wu
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-06       Impact factor: 4.553

Review 2.  Immunotherapy in Ovarian Cancer.

Authors:  Weimin Wang; Janice Rebecca Liu; Weiping Zou
Journal:  Surg Oncol Clin N Am       Date:  2019-04-05       Impact factor: 3.495

Review 3.  Biocompatible Iron Oxide Nanoparticles for Targeted Cancer Gene Therapy: A Review.

Authors:  Jinsong Zhang; Tianyuan Zhang; Jianqing Gao
Journal:  Nanomaterials (Basel)       Date:  2022-09-24       Impact factor: 5.719

4.  Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE.

Authors:  Yi-Hsiang Huang; Masaki Terabe; C David Pendleton; Deborah Stewart Khursigara; Tapan K Bera; Ira Pastan; Jay A Berzofsky
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.